logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Fairley, Elizabeth Anne Lyle, Dr
    Chief Operations Officer, Talking Medicines born in April 1975
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-08-18 ~ now
    OF - Director → CIF 0
  • 2
    Sisto, Albert Ernest
    Ceo born in August 1949
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-11-04 ~ now
    OF - Director → CIF 0
  • 3
    Crae, Scott Fraser
    Chief Medical Officer, Talking Medicines born in July 1969
    Individual (4 offsprings)
    Officer
    icon of calendar 2013-04-10 ~ now
    OF - Director → CIF 0
  • 4
    Halliday, Jo-anne
    Ceo, Talking Medicines born in January 1967
    Individual (6 offsprings)
    Officer
    icon of calendar 2013-04-10 ~ now
    OF - Director → CIF 0
Ceased 6
  • 1
    Dr Elizabeth Anne Lyle Fairley
    Born in April 1975
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2017-03-22 ~ 2017-06-28
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Younger, Simon Clovis
    Engineer born in September 1970
    Individual (6 offsprings)
    Officer
    icon of calendar 2017-07-19 ~ 2020-11-24
    OF - Director → CIF 0
  • 3
    Mr Scott Fraser Crae
    Born in July 1969
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2019-05-09
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 4
    Mrs Jo-anne Halliday
    Born in January 1967
    Individual (6 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2019-05-09
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 5
    Cons, Ben Major George
    Scientist born in March 1966
    Individual (1 offspring)
    Officer
    icon of calendar 2019-05-09 ~ 2022-10-18
    OF - Director → CIF 0
  • 6
    icon of addressSuite 2, Ground Floor, Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom
    Active Corporate (13 parents, 484 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2016-11-11 ~ 2023-07-20
    PE - Secretary → CIF 0
parent relation
Company in focus

TALKING MEDICINES LIMITED

Previous names
PURPLE PET PEOPLE LTD - 2013-11-07
VIRTUAL GENIE LIMITED - 2015-12-04
Standard Industrial Classification
62012 - Business And Domestic Software Development
Brief company account
Property, Plant & Equipment
3,992 GBP2024-12-31
6,144 GBP2023-12-31
Fixed Assets - Investments
3 GBP2024-12-31
3 GBP2023-12-31
Debtors
Current
304,296 GBP2024-12-31
210,344 GBP2023-12-31
Cash at bank and in hand
10,668 GBP2024-12-31
36,756 GBP2023-12-31
Net Assets/Liabilities
-1,418,251 GBP2024-12-31
-908,076 GBP2023-12-31
Equity
Called up share capital
380 GBP2024-12-31
380 GBP2023-12-31
Share premium
3,565,229 GBP2024-12-31
3,565,229 GBP2023-12-31
Retained earnings (accumulated losses)
-4,983,860 GBP2024-12-31
-4,473,685 GBP2023-12-31
Equity
-1,418,251 GBP2024-12-31
-908,076 GBP2023-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
152024-01-01 ~ 2024-12-31
Furniture and fittings
102024-01-01 ~ 2024-12-31
Average Number of Employees
332024-01-01 ~ 2024-12-31
292023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
738 GBP2024-12-31
738 GBP2023-12-31
Furniture and fittings
1,693 GBP2024-12-31
1,693 GBP2023-12-31
Computers
29,619 GBP2024-12-31
28,003 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
32,050 GBP2024-12-31
30,434 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
549 GBP2024-12-31
516 GBP2023-12-31
Furniture and fittings
1,072 GBP2024-12-31
961 GBP2023-12-31
Computers
26,437 GBP2024-12-31
22,813 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
28,058 GBP2024-12-31
24,290 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
33 GBP2024-01-01 ~ 2024-12-31
Furniture and fittings
111 GBP2024-01-01 ~ 2024-12-31
Computers
3,624 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3,768 GBP2024-01-01 ~ 2024-12-31
Investments in Subsidiaries
Cost valuation
3 GBP2024-12-31
3 GBP2023-12-31
Investments in Subsidiaries
3 GBP2024-12-31
3 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
37,140 GBP2024-12-31
27,360 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
72,176 GBP2024-12-31
100,000 GBP2023-12-31
Other Debtors
Current
70,236 GBP2024-12-31
17,318 GBP2023-12-31
Trade Creditors/Trade Payables
Current
195,875 GBP2024-12-31
172,204 GBP2023-12-31
Other Creditors
Current
346,528 GBP2024-12-31
199,159 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
206,813 shares2024-12-31
Par Value of Share
Class 1 ordinary share
0.001 GBP2024-01-01 ~ 2024-12-31
Nominal value of allotted share capital
Class 1 ordinary share
207 GBP2024-01-01 ~ 2024-12-31
207 GBP2023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
173,156 shares2024-12-31
Par Value of Share
Class 2 ordinary share
0.001 GBP2024-01-01 ~ 2024-12-31
Nominal value of allotted share capital
Class 2 ordinary share
173 GBP2024-01-01 ~ 2024-12-31
173 GBP2023-01-01 ~ 2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
0 GBP2024-12-31
2,170 GBP2023-12-31

Related profiles found in government register
  • TALKING MEDICINES LIMITED
    Info
    PURPLE PET PEOPLE LTD - 2013-11-07
    VIRTUAL GENIE LIMITED - 2013-11-07
    Registered number SC447227
    icon of addressC/o Johnston Carmichael, 227 West George Street, Glasgow G2 2ND
    Private Limited Company incorporated on 2013-04-10 (12 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-04
    CIF 0
  • TALKING MEDICINES LIMITED
    S
    Registered number Sc447227
    icon of addressC/o Talking Medicines Ltd, Beco Building, 58 Kingston Street, Glasgow, Scotland, G5 8BP
    Limited By Shares in United Kingdom, Scotland
    CIF 1 CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    icon of addressC/o Talking Medicines Ltd Beco Building, 58 Kingston Street, Glasgow, Scotland
    Active Corporate (4 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    icon of calendar 2020-05-05 ~ now
    CIF 1 - Ownership of voting rights - 75% or moreOE
    CIF 1 - Ownership of shares – 75% or moreOE
  • 2
    icon of addressC/o Talking Medicines Ltd Beco Building, 58 Kingston Street, Glasgow, Scotland
    Active Corporate (4 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    icon of calendar 2020-05-05 ~ now
    CIF 2 - Ownership of shares – 75% or moreOE
    CIF 2 - Ownership of voting rights - 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.